Oncolytic virus therapy mobilizes tumor-resident CD4+ bystander T cells to restore systemic anti-microbial immunity [ATAC-seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 16 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 16 samples: 8 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Oncolytic virotherapy mobilizes tumor-resident, granzyme B-producing bystander CD4(+) T cells to inhibit systemic microbial infectionMolecular therapy. Oncology · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE302620_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1291592 and SRA study SRP601062. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 16 samples.
How we read this: 8 replicated groups read from 16 sample titles; they account for 16 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9107635 Ly108+CD39- SM cells, PBS group, tumor, Rep1 Ly108+CD39- SM cells, P…
- GSM9107636 Ly108+CD39- SM cells, PBS group, tumor, Rep2 Ly108+CD39- SM cells, P…
- GSM9107637 Ly108+CD39- SM cells, NDV-WT group, tumor, Rep1 Ly108+CD39- SM cells, N…
- GSM9107638 Ly108+CD39- SM cells, NDV-WT group, tumor, Rep2 Ly108+CD39- SM cells, N…
- GSM9107639 Ly108+CD39- SM cells, NDV-GP group, tumor, Rep1 Ly108+CD39- SM cells, N…
- GSM9107640 Ly108+CD39- SM cells, NDV-GP group, tumor, Rep2 Ly108+CD39- SM cells, N…
- GSM9107641 Ly108-CD39+ SM cells, NDV-GP group, tumor, Rep1 Ly108-CD39+ SM cells, N…
- GSM9107642 Ly108-CD39+ SM cells, NDV-GP group, tumor, Rep2 Ly108-CD39+ SM cells, N…
- GSM9107643 Ly108+CD39- SM cells, PBS group, spleen, Rep1 Ly108+CD39- SM cells, P…
- GSM9107644 Ly108+CD39- SM cells, PBS group, spleen, Rep2 Ly108+CD39- SM cells, P…
- GSM9107645 Ly108+CD39- SM cells, NDV-WT group, spleen, Rep1 Ly108+CD39- SM cells, N…
- GSM9107646 Ly108+CD39- SM cells, NDV-WT group, spleen, Rep2 Ly108+CD39- SM cells, N…
- GSM9107647 Ly108+CD39- SM cells, NDV-GP group, spleen, Rep1 Ly108+CD39- SM cells, N…
- GSM9107648 Ly108+CD39- SM cells, NDV-GP group, spleen, Rep2 Ly108+CD39- SM cells, N…
- GSM9107649 Ly108-CD39+ SM cells, NDV-GP group, spleen, Rep1 Ly108-CD39+ SM cells, N…
- GSM9107650 Ly108-CD39+ SM cells, NDV-GP group, spleen, Rep2 Ly108-CD39+ SM cells, N…
- GSE298036 Fc-optimized CD40 Agonistic Antibody Induces Tertiary Lymphoid Structures and Systemic Antitumor Immunity in Metastatic Cancer Patients 33 samples shares cd4, systemic, immunity
- GSE325580 NEMO lysine mutant mice reveal ROS-RelA signaling required for optimal CD40-induced humoral immunity [NEMODK_CUTTAG] 60 samples shares cd4, immunity
- GSE309052 The TCR-SUB1-DOCK2 Signaling Axis Governs Autoimmunity by Regulating CD4+ T Cell Migratory Capacity 14 samples shares cd4, immunity
- GSE325579 NEMO lysine mutant mice reveal ROS-RelA signaling required for optimal CD40-induced humoral immunity [NEMODK_ATACSeq] 12 samples shares cd4, immunity
- GSE290982 ATOR-4066, a Neo-X-Prime bispecific antibody targeting CD40 and CEACAM5, induces strong myeloid and T cell dependent tumor immunity 52 samples shares cd4, immunity
- GSE305350 CD27 Agonism Enhances Long-Lived CD4⁺ T Cell Vaccine Responses Critical for 2 Anti-Tumor Immunity 26 samples shares cd4, immunity
- GSE325803 CD40-induced humoral immunity 18 samples shares cd4, immunity
- GSE324687 Eomes sustains progenitor CD4⁺ T helper cells to promote anti-tumor immunity during immunotherapy [scRNA] 16 samples shares cd4, immunity
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.